Clinical trials
Completed Anxiety Disorders trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 7 |
| Federal University of São Paulo | 3 |
| Hospital Israelita Albert Einstein | 3 |
| Hospital de Clinicas de Porto Alegre | 3 |
| D'Or Institute for Research and Education | 2 |
| Pontificia Universidade Católica do Rio Grande do Sul | 2 |
| Universidade Federal do Rio de Janeiro | 2 |
| Barretos Cancer Hospital | 1 |
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | 1 |
| Federal University of Juiz de Fora | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 41 |
| COVID-19 | 4 |
| Neoplasms | 3 |
| Stress Disorders, Post-Traumatic | 3 |
| Panic Disorder | 2 |
| Acute Coronary Syndrome | 1 |
| Agoraphobia | 1 |
| Arrhythmias, Cardiac | 1 |
| Burnout, Professional | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.